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Left ventricular remodeling (LVR) typically manifests as compensatory changes in ventricular 
mass, composition, and volume as a response to cardiac performance inadequacy [1]. Cardiac 
multimodality imaging allows us to investigate both counterparts of remodeling, namely 
structural and functional remodeling [2, 3]. Considering the morbi-mortality burden of LVR, 
these parameters appear to be of value for diagnosing subclinical disease, conducting patient risk 
stratification, and monitoring response to therapy [1].  
 
We present here a bibliographic survey of multimodality imaging in the assessment of LVR. We 
sought to identify all trials that described LVR by means of a substantial imaging method. 
We identified 264 studies from January 2000 to May 2013 by searching the online Medline 
electronic database and by manually examining journals and review articles. 
Post-myocardial infarction (MI) (175 studies, 66%) and cardiac resynchronization therapy (CRT) 
(56 studies, 21%) were the 2 most commonly studied pathologies. 132 were based on human 
bedside research. Most (75%) of the research studies on humans were analytical, whereas 52% of 
those involving animals were interventional. Among human researches, the mean population size 
was 114±192 patients (median: 54 [25-75 percentiles: 37-103]. The mean time for follow-up 
assessment varied: 189±119 days (median: 180 days [25-75 percentiles: 180-180]) for CRT, and 
205±217 days (median: 180 [25-75 percentiles: 120-180]) for post-MI. 
 
Nowadays, cardiac magnetic resonance (CMR) and transthoracic echocardiography (TTE) are the 
two principal tools used for volumetric assessment. They present opposite imaging principles of 
contrast. While contrast in ultrasonography is created by tissue structures, upon which echo 
waves are reflected, free precession CMR imaging sequences, relays on a T2/T1 contrast, that can 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
3 
 
accentuate the naturally low T1 relaxation time of circulating blood. When combined with partial 
volume effects inherent of any imaging method, the myocardium may appear mechanically 
thicker by TTE than by CMR, so that TTE comparatively depicts larger LV mass and smaller 
volumes [4].  
LV volumes and function reproducibility can be affected by the method and type of pathology 
studied, with still agreements to be lower than 5% by CMR [3]. Nevertheless, the differences in 
performance of the various imaging techniques are small.  
The bibliographic survey found out that as CMR being incompatible with CRT, LV volumetric 
parameters were exclusively assessed by TTE (n=56, 100%) – CMR was eventually confined to 
pre-therapy assessment of fibrosis – whereas post-MI studies used both CMR (n=71, 41%) and 
TTE (n=45, 26%).  
 
Imaging is crucial for the assessment of LV volumes and geometry. Despite the many indices that 
have been developed to characterize LV shape, LVR is better assessed by global parameters. 
Above all, LV end-systolic volume (LVESV) present a theoretical advantage, understanding that 
it combines data on both volumetric assessment and systolic function. White et al. [5] 
emphasized LVESV as a strong prognostic factor, incremental to LV ejection fraction. 
Nevertheless, the dichotomous threshold to effectively identify LVR is still debated. In the subset 
of CRT, a decrease in LVESV, from 10% [6] to 15% [7], was related to clinical prognosis and is 
used in 31 studies. In post-MI patients, LVR was defined in 55 (42%) studies using a predefined 
threshold. A 20% increase in LV end-diastolic volume (n=23) was the most common threshold. 
Surprisingly, it was never correlated with morbi-mortality, and the citation flow ends with 
McKay et al. [8]. Published in 1986, invasive LV angiography evaluated LVR between baseline 
and 14 days in patients treated by thrombolysis. Citation flows were drawn (figure 1 and 2). 
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Today, there is a noticeable void in recent prospective studies in the field of post-MI, despite its 
large prevalence and the continuous advances made in medical management [9]. Associations 
should be established on homogenous cohorts of patients, robust imaging methods, and long-term 
cardiac prognosis. 
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Figures 
Figure 1: Citation flow for LV remodeling thresholds in the context of cardiac resynchronization 
therapy. 10% (?) and 15% decrease in LVESV (?) were used in 31 (86%) threshold-using 
studies. 
Figure 2: Citation flow for LV remodeling thresholds in the context of myocardial infarction. 
20% increase in LVEDV (?) and 15% increase in LVESV () were used in 29 (53%) threshold-
using studies (see supplementary references). 
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